Pesce, Amadeo. “Why Pharmacogenetic Testing Should Be Reimbursed by Medicare and Commercial Health Insurance”. Journal of Opioid Management 20, no. 4 (August 1, 2024): 267. Accessed November 24, 2024. https://wmpllc.org/ojs/index.php/jom/article/view/3677.